Hoiseon Jeong, Youngseok Lee, Jungsuk An, Ok Hee Woo, KyongHwa Park, Aeree Kim
{"title":"乳腺浸润性导管癌中高组织学分级和基础型过氧化物酶体增殖物激活受体γ的相关表达","authors":"Hoiseon Jeong, Youngseok Lee, Jungsuk An, Ok Hee Woo, KyongHwa Park, Aeree Kim","doi":"10.1111/j.1755-9294.2009.01053.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p> <b>Backgroud and aim:</b> Peroxisome proliferator-activated receptor γ (PPARγ) is one of the ligand-activated transcription factors belonging to the nuclear hormone receptor family. The protein is expressed in various kinds of tumor and has been implicated as a tumor suppressor in most cancers. We aimed to understand the role of PPARγ in breast cancer. <b>Methods:</b> The expression of PPARγ in 288 cases of invasive ductal carcinoma was examined using tissue microarray and immunohistochemistry. <b>Results:</b> PPARγ immunoreactivity was detected in 21.5% of cases and significantly associated with expression of EGFR and ki-67 (<i>P</i>= 0.008; <i>P</i>= 0.046). PPARγ expression was correlated with high histological grade and basal type (<i>P</i>≤ 0.001; <i>P</i>= 0.009). <b>Conclusions:</b> PPARγ expression is related to poor prognostic factors of breast cancer. It is considered that PPARγ has evident tumor promoting properties <i>in vivo</i>, but receptor-independent effects of PPARγ ligands may compound its biologic effects in cancer. A better understanding of action mechanisms of the activated PPARγ is required.</p>\n </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 4","pages":"118-124"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01053.x","citationCount":"0","resultStr":"{\"title\":\"Correlated expression of peroxisome proliferator-activated receptor γ with high histologic grade and basal type in invasive ductal carcinoma of the breast\",\"authors\":\"Hoiseon Jeong, Youngseok Lee, Jungsuk An, Ok Hee Woo, KyongHwa Park, Aeree Kim\",\"doi\":\"10.1111/j.1755-9294.2009.01053.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p> <b>Backgroud and aim:</b> Peroxisome proliferator-activated receptor γ (PPARγ) is one of the ligand-activated transcription factors belonging to the nuclear hormone receptor family. The protein is expressed in various kinds of tumor and has been implicated as a tumor suppressor in most cancers. We aimed to understand the role of PPARγ in breast cancer. <b>Methods:</b> The expression of PPARγ in 288 cases of invasive ductal carcinoma was examined using tissue microarray and immunohistochemistry. <b>Results:</b> PPARγ immunoreactivity was detected in 21.5% of cases and significantly associated with expression of EGFR and ki-67 (<i>P</i>= 0.008; <i>P</i>= 0.046). PPARγ expression was correlated with high histological grade and basal type (<i>P</i>≤ 0.001; <i>P</i>= 0.009). <b>Conclusions:</b> PPARγ expression is related to poor prognostic factors of breast cancer. It is considered that PPARγ has evident tumor promoting properties <i>in vivo</i>, but receptor-independent effects of PPARγ ligands may compound its biologic effects in cancer. A better understanding of action mechanisms of the activated PPARγ is required.</p>\\n </div>\",\"PeriodicalId\":92990,\"journal\":{\"name\":\"Basic and applied pathology\",\"volume\":\"2 4\",\"pages\":\"118-124\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01053.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic and applied pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1755-9294.2009.01053.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic and applied pathology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1755-9294.2009.01053.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Correlated expression of peroxisome proliferator-activated receptor γ with high histologic grade and basal type in invasive ductal carcinoma of the breast
Backgroud and aim: Peroxisome proliferator-activated receptor γ (PPARγ) is one of the ligand-activated transcription factors belonging to the nuclear hormone receptor family. The protein is expressed in various kinds of tumor and has been implicated as a tumor suppressor in most cancers. We aimed to understand the role of PPARγ in breast cancer. Methods: The expression of PPARγ in 288 cases of invasive ductal carcinoma was examined using tissue microarray and immunohistochemistry. Results: PPARγ immunoreactivity was detected in 21.5% of cases and significantly associated with expression of EGFR and ki-67 (P= 0.008; P= 0.046). PPARγ expression was correlated with high histological grade and basal type (P≤ 0.001; P= 0.009). Conclusions: PPARγ expression is related to poor prognostic factors of breast cancer. It is considered that PPARγ has evident tumor promoting properties in vivo, but receptor-independent effects of PPARγ ligands may compound its biologic effects in cancer. A better understanding of action mechanisms of the activated PPARγ is required.